申请人:CIBA-GEIGY AG
公开号:EP0372470A3
公开(公告)日:1991-07-10
-(Substituted carbamoyl)-β-aryl- and heteroaryl-β-oxopropionitriles of formula
enol ethers thereof and salts thereof, as well as pharmaceutical preparations containing same and methods of preparing and using these compounds are disclosed. Said compounds represent novel antiinflammatory and antirheumatic agents. Their property to interfere with both the cyclooxygenase and lipoxygenase pathway of the arachidonic fatty acid bioconversion to inflammatory mediators make them valuable therapeutics. These properties render the mentioned substituted carbamoyl-β-oxopropionitriles useful for the treatment of arthritic and rheumatic diseases and other inflammatory conditions in mammals.
本文披露了公式的-(替代氨基甲酰基)-β-芳基和杂芳基-β-氧代丙腈及其醚和盐,以及含有它们的药物制剂,以及制备和使用这些化合物的方法。这些化合物代表了新型的抗炎和抗风湿药物。它们干预花生四烯酸脂肪酸生物转化为炎症介质的环氧化酶和脂氧化酶途径的能力使它们成为有价值的治疗药物。这些特性使得上述的-(替代氨基甲酰基)-β-氧代丙腈对治疗哺乳动物的关节炎、风湿病和其他炎症病症有用。